Will screening for breast cancer reduce mortality? Evidence from the first year of screening in Avon.
In the first year of screening in Avon, 93 malignant lesions were detected of which one-half were impalpable. Of the impalpable lesions, one-half were in situ or showed areas of microinvasion only. One-fifth of the malignant lesions were invasive tumours of special histological type which are known to carry a good prognosis even when not detected by screening. One-quarter of the lesions had clinical or pathological features which would be expected to confer a poor prognosis. Only 16 invasive ductal carcinomas measuring 1 cm or less in diameter were detected--a small proportion of the total number of malignant lesions. Although these early figures suggest that the effect of screening on mortality from breast cancer may be small, continued high-quality screening and careful detailed analysis are essential to determine the effect of screening on the mortality from breast cancer and the effect on the population as a whole.
Nicholson
S
S
Regional Breast Screening Pathology Unit, Southmead Hospital, Bristol.
Webb
A J
AJ
Coghlan
B
B
Farndon
J R
JR
Armstrong
J S
JS
Davies
J D
JD
D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D002278:Carcinoma in Situ / Q000517:prevention & control; D004739:England / Q000453:epidemiology; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D009313:National Health Programs; D011379:Prognosis